Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sosman

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Investigational New Drugs|September 20, 2001
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerB Brockstein, B Samuels, R Humerickhouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium studyW M Stadler, N J Vogelzang, R Amato, et al.
AIDS and Behavior|November 30, 2011
Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project STARTA P Johnson, R J Macgowan, G D Eldridge, et al.
Clinical Allergy|March 1, 1973
Metabolic changes in exercise-induced asthmaJ J Barboriak, A J Sosman, J N Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanomaM B Atkins, B Redman, J Mier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trialP J Stiff, R Bayer, S Tan, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trialsM B Atkins, J Dutcher, G Weiss, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokinesJ Dutcher, M B Atkins, K Margolin, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcomeP Stiff, R Bayer, M Camarda, et al.
Bone Marrow Transplantation|September 12, 2000
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseK van Besien, A Bartholomew, W Stock, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|September 20, 2001
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancerB Brockstein, B Samuels, R Humerickhouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium studyW M Stadler, N J Vogelzang, R Amato, et al.
AIDS and Behavior|November 30, 2011
Cost and threshold analysis of an HIV/STI/hepatitis prevention intervention for young men leaving prison: Project STARTA P Johnson, R J Macgowan, G D Eldridge, et al.
Clinical Allergy|March 1, 1973
Metabolic changes in exercise-induced asthmaJ J Barboriak, A J Sosman, J N Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanomaM B Atkins, B Redman, J Mier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trialP J Stiff, R Bayer, S Tan, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trialsM B Atkins, J Dutcher, G Weiss, et al.
Medical Oncology (Northwood, London, England)|March 29, 2002
Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokinesJ Dutcher, M B Atkins, K Margolin, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcomeP Stiff, R Bayer, M Camarda, et al.
Bone Marrow Transplantation|September 12, 2000
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseK van Besien, A Bartholomew, W Stock, et al.
Pageof 4